Phototherapy: The method used in the treatment of chronic dermatological diseases

[1]Singer S., Berneburg M.: Phototherapy. J. Dtsch. Dermatol. Ges., 2018; 16: 1120-1129Singer S. Berneburg M. Phototherapy J. Dtsch. Dermatol. Ges 2018 16 1120 112910.1111/ddg.13646Search in Google Scholar

[2]Nagy E.M., Dalla Via L., Ronconi L., Fregona D.: Recent advances in PUVA photochemotherapy and PDT for the treatment of cancer. Curr. Pharm. Des., 2010; 16: 1863-1876Nagy E.M. Dalla Via L. Ronconi L. Fregona D. Recent advances in PUVA photochemotherapy and PDT for the treatment of cancer Curr. Pharm. Des 2010 16 1863 187610.2174/138161210791209018Search in Google Scholar

[3]Ackroyd R., Kelty C., Brown N., Reed M.: The history of photodetection and photodynamic therapy. Photochem. Photobiol., 2001; 74: 656-669Ackroyd R. Kelty C. Brown N. Reed M. The history of photodetection and photodynamic therapy Photochem. Photobiol 2001 74 656 66910.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO;2Search in Google Scholar

[4]Duarte I., Buense R., Kobata C.: Phototherapy. An. Bras. Dermatol., 2006; 81: 74-82Duarte I. Buense R. Kobata C. Phototherapy An. Bras. Dermatol 2006 81 74 8210.1590/S0365-05962006000100010Search in Google Scholar

[5]Matsumura Y., Ananthaswamy H.N.: Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol., 2004; 195: 298-308Matsumura Y. Ananthaswamy H.N. Toxic effects of ultraviolet radiation on the skin Toxicol. Appl. Pharmacol 2004 195 298 30810.1016/j.taap.2003.08.019Search in Google Scholar

[6]Bailey E.E., Ference E.H., Alikhan A., Hession M.T., Armstrong A.W.: Combination treatments for psoriasis: A systematic review and meta-analysis. Arch. Dermatol., 2012; 148: 511-522Bailey E.E. Ference E.H. Alikhan A. Hession M.T. Armstrong A.W. Combination treatments for psoriasis: A systematic review and meta-analysis Arch. Dermatol 2012 148 511 52210.1001/archdermatol.2011.1916Search in Google Scholar

[7]Mohania D., Chandel S., Kumar P., Verma V., Digvijay K., Tripathi D., Choudhury K., Mitten S.K., Shah D.: Ultraviolet radiations: Skin defense-damage mechanism. Adv. Exp. Med. Biol., 2017; 996: 7187Mohania D. Chandel S. Kumar P. Verma V. Digvijay K. Tripathi D. Choudhury K. Mitten S.K. Shah D. Ultraviolet radiations: Skin defense-damage mechanism Adv. Exp. Med. Biol 2017 996 718710.1007/978-3-319-56017-5_7Search in Google Scholar

[8]Young A.R., Claveau J., Rossi A.B.: Ultraviolet radiation and the skin: Photobiology and sunscreen photoprotection. J. Am. Acad. Dermatol., 2017; 76: 100-109Young A.R. Claveau J. Rossi A.B. Ultraviolet radiation and the skin: Photobiology and sunscreen photoprotection J. Am. Acad. Dermatol 2017 76 100 10910.1016/j.jaad.2016.09.038Search in Google Scholar

[9]Ibbotson S.H.: A perspective on the use of NB-UVB phototherapy vs. PUVA photochemotherapy. Front. Med., 2018; 5: 184Ibbotson S.H. A perspective on the use of NB-UVB phototherapy vs PUVA photochemotherapy. Front. Med 2018 5 18410.3389/fmed.2018.00184Search in Google Scholar

[10]Jiang A.J., Lim H.W.: Phototherapy in the evaluation and management of photodermatoses. Dermatol. Clin., 2020; 38: 71-77Jiang A.J. Lim H.W. Phototherapy in the evaluation and management of photodermatoses Dermatol. Clin 2020 38 71 7710.1016/j.det.2019.08.007Search in Google Scholar

[11]Juarez M.C., Grossberg A.L.: Phototherapy in the pediatric population. Dermatol. Clin., 2020; 38: 91-108Juarez M.C. Grossberg A.L. Phototherapy in the pediatric population Dermatol. Clin 2020 38 91 10810.1016/j.det.2019.08.01231753196Search in Google Scholar

[12]Maitray A., Rishi P.: Methoxsalen-induced macular toxicity. Indian J. Ophthalmol., 2017; 65: 1243-1245Maitray A. Rishi P. Methoxsalen-induced macular toxicity Indian J. Ophthalmol 2017 65 1243 124510.4103/ijo.IJO_413_17570060929133667Search in Google Scholar

[13]Klimas K., Fischer A.: Reakcja fototoksyczna i czynniki ją wywołujące. Alergologia Info, 2018; 4: 83-88Klimas K. Fischer A. Reakcja fototoksyczna i czynniki ją wywołujące Alergologia Info 2018 4 83 88Search in Google Scholar

[14]Bulat V., Situm M., Dediol I., Ljubicić I., Bradić L.: The mechanisms of action of phototherapy in the treatment of the most common dermatoses. Coll. Antropol., 2011; 35: 147-151Bulat V. Situm M. Dediol I. Ljubicić I. Bradić L. The mechanisms of action of phototherapy in the treatment of the most common dermatoses Coll. Antropol 2011 35 147 151Search in Google Scholar

[15]Maleki M., Yazdanpanah M.J., Hamidi H., Jokar L.: Evaluation of PUVA-induced skin side effects in patients referred to the Imam Reza Hospital of Mashhad in 2005-2007. Indian J. Dermatol., 2014; 59: 209Maleki M. Yazdanpanah M.J. Hamidi H. Jokar L. Evaluation of PUVA-induced skin side effects in patients referred to the Imam Reza Hospital of Mashhad in 2005-2007 Indian J. Dermatol 2014 59 20910.4103/0019-5154.127708396969724700955Search in Google Scholar

[16]Briganti S., Wlaschek M., Hinrichs C., Bellei B., Flori E., Treiber N., Iben S., Picardo M., Scharffetter-Kochanek K.: Small molecular antioxidants effectively protect from PUVA-induced oxidative stress responses underlying fibroblast senescence and photoaging. Free Radic. Biol. Med., 2008; 45: 636-44Briganti S. Wlaschek M. Hinrichs C. Bellei B. Flori E. Treiber N. Iben S. Picardo M. Scharffetter-Kochanek K. Small molecular antioxidants effectively protect from PUVA-induced oxidative stress responses underlying fibroblast senescence and photoaging Free Radic. Biol. Med 2008 45 636 4410.1016/j.freeradbiomed.2008.05.00618538675Search in Google Scholar

[17]Turbay S., Piro O.E., Echeverría G.A., Navarro A., Fernández-Liencres M.P., Fortuna M., Tuttolomondo M.E.: Theoretical and experimental study of a novel psolaren derivate: (E)-9-(3,4-dimethylpent-2-enyloxy)-7H-furo[3,2-g]chromen-7-one. Spectrochim. Acta A. Mol. Biomol. Spectrosc., 2014; 123: 71-77Turbay S. Piro O.E. Echeverría G.A. Navarro A. Fernández-Liencres M.P. Fortuna M. Tuttolomondo M.E. Theoretical and experimental study of a novel psolaren derivate: (E)-9-(3,4-dimethylpent-2-enyloxy)-7H-furo[3,2-g]chromen-7-one Spectrochim. Acta A. Mol. Biomol. Spectrosc 2014 123 71 7710.1016/j.saa.2013.12.02824389002Search in Google Scholar

[18]Bartnik M., Mazurek A.K.: Isolation of methoxyfuranocoumarins from Ammi majus by centrifugal partition chromatography. J. Chromatogr. Sci., 2016; 54: 10-16Bartnik M. Mazurek A.K. Isolation of methoxyfuranocoumarins from Ammi majus by centrifugal partition chromatography J. Chromatogr. Sci 2016 54 10 1610.1093/chromsci/bmv098Search in Google Scholar

[19]Salińska M., Kowalska H., Torzecka J.D., Waszczykowska E., Woźniacka A.: Phototoxic reaction due to solar radiation exposure in a psoriatic patient treated with PUVA therapy. Med. Pr., 2019; 70: 763-768Salińska M. Kowalska H. Torzecka J.D. Waszczykowska E. Woźniacka A. Phototoxic reaction due to solar radiation exposure in a psoriatic patient treated with PUVA therapy Med. Pr 2019 70 763 76810.13075/mp.5893.0088131512683Search in Google Scholar

[20]Kemény L., Varga E., Novak Z.: Advances in phototherapy for psoriasis and atopic dermatitis. Expert Rev. Clin. Immunol,. 2019; 15: 1205-1214Kemény L. Varga E. Novak Z. Advances in phototherapy for psoriasis and atopic dermatitis Expert Rev. Clin. Immunol 2019 15 1205 121410.1080/1744666X.2020.167253731575297Search in Google Scholar

[21]Khanna N., Nazli T., Siddiqui K.M., Kalaivani M., Rais-ur-Rahman.: A non-inferiority randomized controlled clinical trial comparing Unani formulation & psoralen plus ultraviolet A sol in chronic plaque psoriasis. Indian J. Med. Res., 2018; 147: 66-72Khanna N. Nazli T. Siddiqui K.M. Kalaivani M. Rais-ur-Rahman A non-inferiority randomized controlled clinical trial comparing Unani formulation & psoralen plus ultraviolet A sol in chronic plaque psoriasis Indian J. Med. Res 2018 147 66 7210.4103/ijmr.IJMR_249_16596721929749363Search in Google Scholar

[22]Ware O.R., Guiyab J., Okoye G.A.: Phototherapy in skin of color. Dermatol. Clin., 2020; 38: 63-69Ware O.R. Guiyab J. Okoye G.A. Phototherapy in skin of color Dermatol. Clin 2020 38 63 6910.1016/j.det.2019.08.00631753193Search in Google Scholar

[23]Richard E.G.: The science and (lost) art of psoralen plus UVA phototherapy. Dermatol. Clin., 2020; 38: 11-23Richard E.G. The science and (lost) art of psoralen plus UVA phototherapy Dermatol. Clin 2020 38 11 2310.1016/j.det.2019.08.00231753184Search in Google Scholar

[24]Sadowska M., Lesiak A., Narbutt J.: Application of phototherapy in the treatment of psoriasis vulgaris. Dermatol. Rev., 2019; 106: 198-209Sadowska M. Lesiak A. Narbutt J. Application of phototherapy in the treatment of psoriasis vulgaris Dermatol. Rev 2019 106 198 20910.5114/dr.2019.85577Search in Google Scholar

[25]Farahnik B., Nakamura M., Singh R.K., Abrouk M., Zhu T.H., Lee K.M., Jose M.V., DaLovisio R., Koo J., Bhutani T., Liao W.: The patient’s guide to psoriasis treatment. Part 2: PUVA phototherapy. Dermatol. Ther., 2016; 6: 315-324Farahnik B. Nakamura M. Singh R.K. Abrouk M. Zhu T.H. Lee K.M. Jose M.V. DaLovisio R. Koo J. Bhutani T. Liao W. The patient’s guide to psoriasis treatment Part 2: PUVA phototherapy. Dermatol. Ther 2016 6 315 32410.1007/s13555-016-0130-9Search in Google Scholar

[26]Errichetti E., Piccirillo A., Ricciuti F., Ricciuti F.: Steroid-resistant localized lymphomatoid papulosis treated with local bath-PUVA therapy. Indian J. Dermatol., 2013; 58: 163Errichetti E. Piccirillo A. Ricciuti F. Ricciuti F. Steroid-resistant localized lymphomatoid papulosis treated with local bath-PUVA therapy Indian J. Dermatol 2013 58 16310.4103/0019-5154.108109365726523716855Search in Google Scholar

[27]Kubo R., Muramatsu S., Sagawa Y., Saito C., Kasuya S., Nishioka A., Nishida E., Yamazaki S., Morita A.: Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis. J. Dermatol. Sci., 2017; 86: 46-53Kubo R. Muramatsu S. Sagawa Y. Saito C. Kasuya S. Nishioka A. Nishida E. Yamazaki S. Morita A. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis J. Dermatol. Sci 2017 86 46 5310.1016/j.jdermsci.2017.01.00128139335Search in Google Scholar

[28]Elmets C.A., Lim H.W., Stoff B., Connor C., Cordoro K.M., Lebwohl M., Armstrong A.W., Davis D.M., Elewski B.E., Gelfand J.M. i wsp.: Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J. Am. Acad. Dermatol., 2019; 81:775-804Elmets C.A. Lim H.W. Stoff B. Connor C. Cordoro K.M. Lebwohl M. Armstrong A.W. Davis D.M. Elewski B.E. Gelfand J.M. i wsp. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy J. Am. Acad. Dermatol 2019 81775 80410.1016/j.jaad.2019.04.04231351884Search in Google Scholar

[29]Yu Z., Wolf P.: How it works: The immunology underlying phototherapy. Dermatol. Clin., 2020; 38: 37-53Yu Z. Wolf P. How it works: The immunology underlying phototherapy Dermatol. Clin 2020 38 37 5310.1016/j.det.2019.08.00431753191Search in Google Scholar

[30]Zhang P., Wu M.X.: A clinical review of phototherapy for psoriasis. Lasers Med. Sci., 2018; 33: 173-180Zhang P. Wu M.X. A clinical review of phototherapy for psoriasis Lasers Med. Sci 2018 33 173 18010.1007/s10103-017-2360-1575656929067616Search in Google Scholar

[31]El-Zawahry B.M., Elmasry M.F., Ragab A.: The role of long-wavelength ultraviolet A1 (UVA1) in acral vitiligo. J. Cosmet. Dermatol., 2019; 18:1155-1160El-Zawahry B.M. Elmasry M.F. Ragab A. The role of long-wavelength ultraviolet A1 (UVA1) in acral vitiligo J. Cosmet. Dermatol 2019 181155 116010.1111/jocd.1280830375144Search in Google Scholar

[32]Zhang T., Shen Z., Zheng J., Jiang R.: Effect of UVA1 on hypertrophic scarring in the rabbit ear model. Biosci. Rep., 2020; 40: BSR20190007Zhang T. Shen Z. Zheng J. Jiang R. Effect of UVA1 on hypertrophic scarring in the rabbit ear model Biosci. Rep 2020 40 BSR2019000710.1042/BSR20190007697442031894858Search in Google Scholar

[33]Keyal U., Bhatta A.K, Wang X.L.: UVA1 a promising approach for scleroderma. Am. J. Transl. Res., 2017; 9: 4280-4287Keyal U. Bhatta A.K Wang X.L. UVA1 a promising approach for scleroderma Am. J. Transl. Res 2017 9 4280 4287Search in Google Scholar

[34]Connolly K.L., Griffith J.L., McEvoy M., Lim H.W.: Ultraviolet Al phototherapy beyond morphea: Experience in 83 patients. Photodermatol. Photoimmunol. Photomed., 2015; 31: 289-295Connolly K.L. Griffith J.L. McEvoy M. Lim H.W. Ultraviolet Al phototherapy beyond morphea: Experience in 83 patients Photodermatol. Photoimmunol. Photomed 2015 31 289 29510.1111/phpp.1218526052743Search in Google Scholar

[35]Prasad S., Coias J., Chen H.W., Jacobe H.: Utilizing UVA-1 phototherapy. Dermatol. Clin., 2020; 38: 79-90Prasad S. Coias J. Chen H.W. Jacobe H. Utilizing UVA-1 phototherapy Dermatol. Clin 2020 38 79 9010.1016/j.det.2019.08.01131753195Search in Google Scholar

[36]Pacifico A., Iacovelli P., Damiani G., Ferraro C., Cazzaniga S., Conic R.R., Leone G., Morrone A.: ‘High dose’ vs. ‘medium dose’ UVA1 phototherapy in italian patients with severe atopic dermatitis. J. Eur. Acad. Dermatol. Venereol., 2019; 33: 718-724Pacifico A. Iacovelli P. Damiani G. Ferraro C. Cazzaniga S. Conic R.R. Leone G. Morrone A. ‘High dose’ vs ‘medium dose’ UVA1 phototherapy in italian patients with severe atopic dermatitis. J. Eur. Acad. Dermatol. Venereol 2019 33 718 72410.1111/jdv.15362Search in Google Scholar

[37]Kohli I., Braunberger T.L., Nahhas A.F., Mirza F.N., Mokhtari M., Lyons A.B., Kollias N., Ruvolo E., Lim H.W., Hamzavi I.H.: Long-wavelength ultraviolet A1 and visible light photoprotection: A multimodality assessment of dose and response. Photochem. Photobiol., 2020; 96: 208-214Kohli I. Braunberger T.L. Nahhas A.F. Mirza F.N. Mokhtari M. Lyons A.B. Kollias N. Ruvolo E. Lim H.W. Hamzavi I.H. Long-wavelength ultraviolet A1 and visible light photoprotection: A multimodality assessment of dose and response Photochem. Photobiol 2020 96 208 21410.1111/php.1315731464341Search in Google Scholar

[38]Khanna U., Khandpur S.: What is new in narrow-band ultraviolet-B therapy for vitiligo? Indian Dermatol. Online J., 2019; 10: 234243Khanna U. Khandpur S. What is new in narrow-band ultraviolet-B therapy for vitiligo? Indian Dermatol Online J 2019 10 23424310.4103/idoj.IDOJ_310_18Search in Google Scholar

[39]Mehta D., Lim H.W.: Ultraviolet B phototherapy for psoriasis: Review of practical guidelines. Am. J. Clin. 2016; 17: 125-133Mehta D. Lim H.W. Ultraviolet B phototherapy for psoriasis: Review of practical guidelines Am. J. Clin 2016 17 125 13310.1007/s40257-016-0176-626872953Search in Google Scholar

[40]Pacifico A., Damiani G., Iacovelli P., Conic R.R., Scarabello A., Filoni A., Malagoli P., Bragazzi N.L., Pigatto P.D., Morrone A.: Photoadaptation to UVB TL01 in psoriatic patients. J. Eur. Acad. Dermatol. Venereol., 2020; 34: 1750-1754Pacifico A. Damiani G. Iacovelli P. Conic R.R. Scarabello A. Filoni A. Malagoli P. Bragazzi N.L. Pigatto P.D. Morrone A. Photoadaptation to UVB TL01 in psoriatic patients J. Eur. Acad. Dermatol. Venereol 2020 34 1750 175410.1111/jdv.1620931967696Search in Google Scholar

[41]Rajpara A.N., O’Neill J.L., Dermatol., Nolan B.V., Yentzer B.A., Feldman S.R.: Review of home phototherapy. Dermatol. Online J., 2010; 16: 2Rajpara A.N. O’Neill J.L. Dermatol Nolan B.V. Yentzer B.A. Feldman S.R. Review of home phototherapy Dermatol. Online J 2010 16 210.5070/D32TS6S057Search in Google Scholar

[42]Lozinski A., Barzilai A., Pavlotsky F.: Broad-band UVB versus paint PUVA for palmoplantar psoriasis treatment. J. Dermatolog. Treat., 2016; 27: 221-223Lozinski A. Barzilai A. Pavlotsky F. Broad-band UVB versus paint PUVA for palmoplantar psoriasis treatment J. Dermatolog. Treat 2016 27 221 22310.3109/09546634.2015.109358826481287Search in Google Scholar

[43]Köster W., Wiskemann A.: Phototherapy with UV-B in vitiligo. Z. Hautkr., 1990; 65: 1022-1024, 1029Köster W. Wiskemann A. Phototherapy with UV-B in vitiligo Z. Hautkr 1990 65 1022 1024 1029Search in Google Scholar

[44]Doghaim N.N., El-Tatawy R.A., Ismail M.A., Ali D.A.M., El Attar Y.A.: Study the effect of erbium:YAG laser plus topical 5_‐flurouracil in stable vitiligo resistant to NB_‐UVB phototherapy. J. Cosmet. Dermatol., 2020; 19: 122-130Doghaim N.N. El-Tatawy R.A. Ismail M.A. Ali D.A.M. El Attar Y.A. Study the effect of erbium:YAG laser plus topical 5_‐flurouracil in stable vitiligo resistant to NB_‐UVB phototherapy J. Cosmet. Dermatol 2020 19 122 13010.1111/jocd.1313431571367Search in Google Scholar

[45]Khater M.H., AbdallaAlhabib S., Elkshishy K.A., Khattab F.M.: Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy. J. Dermatolog. Treat., 2020; 31: 758-762Khater M.H. AbdallaAlhabib S. Elkshishy K.A. Khattab F.M. Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy J. Dermatolog. Treat 2020 31 758 76210.1080/09546634.2019.167077831557066Search in Google Scholar

[46]Ortiz-Salvador J.M., Pérez-Ferriols A.: Phototherapy in atopic dermatitis. Adv. Exp. Med. Biol., 2017; 996: 279-286Ortiz-Salvador J.M. Pérez-Ferriols A. Phototherapy in atopic dermatitis Adv. Exp. Med. Biol 2017 996 279 28610.1007/978-3-319-56017-5_2329124708Search in Google Scholar

[47]Khemis A., Fontas E., Moulin S., Montaudié H., Lacour J.P., Passeron T.: Apremilast in combination with narrowband UVB in the treatment of vitiligo: A 52-week monocentric prospective randomized placebo-controlled study. J. Invest. Dermatol., 2020; 140: 1533-1537.e2Khemis A. Fontas E. Moulin S. Montaudié H. Lacour J.P. Passeron T. Apremilast in combination with narrowband UVB in the treatment of vitiligo: A 52-week monocentric prospective randomized placebo-controlled study J. Invest. Dermatol 2020 140 1533 1537 e210.1016/j.jid.2019.11.03132004567Search in Google Scholar

[48]Silpa-Archa N., Weerasubpong P., Junsuwan N., Yothachai P., Supapueng O., Wongpraparut C.: Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo. J. Dermatolog. Treat., 2019; 30: 691-696Silpa-Archa N. Weerasubpong P. Junsuwan N. Yothachai P. Supapueng O. Wongpraparut C. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo J. Dermatolog. Treat 2019 30 691 69610.1080/09546634.2018.154440930474443Search in Google Scholar

[49]Ocampo-Garza J., Salinas-Santander M., Welsh O., Herz-Ruelas M., Ocampo-Candiani J.: Expression of melanocortin 1 receptor before and after narrowband UVB phototherapy treatment in patients with stable vitiligo: A prospective study. Exp. Ther. Med., 2020; 19: 1649-1654Ocampo-Garza J. Salinas-Santander M. Welsh O. Herz-Ruelas M. Ocampo-Candiani J. Expression of melanocortin 1 receptor before and after narrowband UVB phototherapy treatment in patients with stable vitiligo: A prospective study Exp. Ther. Med 2020 19 1649 165410.3892/etm.2020.8435702714832104216Search in Google Scholar

[50]Arora C.J., Rafiq M., Shumack S., Gupta M.: The efficacy and safety of tacrolimus as mono- and adjunctive therapy for vitiligo: A systematic review of randomised clinical trials. Australas. J. Dermatol., 2020; 61: e1-e9Arora C.J. Rafiq M. Shumack S. Gupta M. The efficacy and safety of tacrolimus as mono- and adjunctive therapy for vitiligo: A systematic review of randomised clinical trials Australas. J. Dermatol 2020 61 e1 e910.1111/ajd.1309631267534Search in Google Scholar

[51]Thompson K.G., Kim N.: Distinguishing myth from fact: Photocarcinogenesis and phototherapy. Dermatol. Clin., 2020; 38: 25-35Thompson K.G. Kim N. Distinguishing myth from fact: Photocarcinogenesis and phototherapy Dermatol. Clin 2020 38 25 3510.1016/j.det.2019.08.00331753190Search in Google Scholar

[52]Esmat S., Hegazy R.A., Shalaby S., Hu S.C., Lan C.E.: Phototherapy and combination therapies for vitiligo. Dermatol. Clin., 2017; 35: 171-192Esmat S. Hegazy R.A. Shalaby S. Hu S.C. Lan C.E. Phototherapy and combination therapies for vitiligo Dermatol. Clin 2017 35 171 19210.1016/j.det.2016.11.00828317527Search in Google Scholar

[53]Shirasu N., Nam S.O., Kuroki M.: Tumor-targeted photodynamic therapy. Anticancer Res., 2013; 33: 2823-2831Shirasu N. Nam S.O. Kuroki M. Tumor-targeted photodynamic therapy Anticancer Res 2013 33 2823 2831Search in Google Scholar

[54]Luo D., Carter K.A., Miranda D., Lovell J.F.: Chemophototherapy: An emerging treatment option for solid tumors. Adv. Sci., 2016; 4: 1600106Luo D. Carter K.A. Miranda D. Lovell J.F. Chemophototherapy: An emerging treatment option for solid tumors Adv. Sci 2016 4 160010610.1002/advs.201600106523875128105389Search in Google Scholar

[55]Rkein A.M., Ozog D.M.: Photodynamic therapy. Dermatol. Clin., 2014; 32: 415-425Rkein A.M. Ozog D.M. Photodynamic therapy Dermatol. Clin 2014 32 415 42510.1016/j.det.2014.03.00924891062Search in Google Scholar

[56]Kwaśny M.: Metoda fotodynamicznego leczenia w dermatologii. Forum Dermatol., 2018; 4: 138-147Kwaśny M. Metoda fotodynamicznego leczenia w dermatologii Forum Dermatol 2018 4 138 147Search in Google Scholar

[57]Rojkiewicz M., Kozik W., Czapka M., Jarzembek K., Zięba G., Kuś P., Kozik V.: Fotodynamiczna terapia nowotworów. Probl. Ekol., 2010; 14: 196-204Rojkiewicz M. Kozik W. Czapka M. Jarzembek K. Zięba G. Kuś P. Kozik V. Fotodynamiczna terapia nowotworów Probl. Ekol 2010 14 196 204Search in Google Scholar

[58]Kessel D., Oleinick N.L.: Photodynamic therapy and cell death pathways. Methods Mol. Biol., 2010; 635: 35-46Kessel D. Oleinick N.L. Photodynamic therapy and cell death pathways Methods Mol. Biol 2010 635 35 4610.1007/978-1-60761-697-9_3445596520552338Search in Google Scholar

[59]Buytaert E., Dewaele M., Agostinis P.: Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta., 2007; 1776: 86-107Buytaert E. Dewaele M. Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy Biochim. Biophys. Acta 2007 1776 86 10710.1016/j.bbcan.2007.07.00117693025Search in Google Scholar

[60]Chilakamarthi U., Giribabu L.: Photodynamic therapy: Past, present and future. Chem. Rec., 2017; 17: 775-802Chilakamarthi U. Giribabu L. Photodynamic therapy: Past, present and future Chem. Rec 2017 17 775 80210.1002/tcr.20160012128042681Search in Google Scholar

[61]Moriwaki K., Sawada T., Akiyama M., Ikeda A., Kikuchi J., Matsumura T., Yano S., Katayoka H., Inoue M., Akashi H.: Synthesis and photophysical properties of S-mannosylated chlorins and their effect on photocytotoxicity in HeLa cells. Bull. Chem. Soc. Jpn., 2018; 91: 230-236Moriwaki K. Sawada T. Akiyama M. Ikeda A. Kikuchi J. Matsumura T. Yano S. Katayoka H. Inoue M. Akashi H. Synthesis and photophysical properties of S-mannosylated chlorins and their effect on photocytotoxicity in HeLa cells Bull. Chem. Soc. Jpn 2018 91 230 23610.1246/bcsj.20170271Search in Google Scholar

[62]Yoon I., Li J.Z., Shim Y.K.: Advance in photosensitizers and light delivery for photodynamic therapy. Clin. Endosc., 2013; 46: 7-23Yoon I. Li J.Z. Shim Y.K. Advance in photosensitizers and light delivery for photodynamic therapy Clin. Endosc 2013 46 7 2310.5946/ce.2013.46.1.7357235523423543Search in Google Scholar

[63]Kwiatkowski S., Knap B., Przystupski D., Saczko J., Kędzierska E., Knap-Czop K., Kotlińska J., Michel O., Kotowski K., Kulbacka J.: Photodynamic therapy – mechanisms, photosensitizers and combinations. Biomed. Pharmacother., 2018; 106: 1098-1107Kwiatkowski S. Knap B. Przystupski D. Saczko J. Kędzierska E. Knap-Czop K. Kotlińska J. Michel O. Kotowski K. Kulbacka J. Photodynamic therapy – mechanisms, photosensitizers and combinations Biomed. Pharmacother 2018 106 1098 110710.1016/j.biopha.2018.07.04930119176Search in Google Scholar

[64]Babilas P., Schreml S., Landthaler M., Szeimies R.M.: Photodynamic therapy in dermatology: State-of-the-art. Photodermatol. Photoimmunol. Photomed., 2010; 26: 118-132Babilas P. Schreml S. Landthaler M. Szeimies R.M. Photodynamic therapy in dermatology: State-of-the-art Photodermatol. Photoimmunol. Photomed 2010 26 118 13210.1111/j.1600-0781.2010.00507.x20584250Search in Google Scholar

[65]Prażmo E.J., Kwaśny M., Łapiński M., Mielczarek A.: Photodynamic therapy as a promising method used in the treatment of oral diseases. Adv. Clin. Exp. Med., 2016; 25: 799-807Prażmo E.J. Kwaśny M. Łapiński M. Mielczarek A. Photodynamic therapy as a promising method used in the treatment of oral diseases Adv. Clin. Exp. Med 2016 25 799 80710.17219/acem/3248827629857Search in Google Scholar

[66]Minchinton A.I., Tannock I.F.: Drug penetration in solid tumors. Nat. Rev. Cancer, 2006; 6: 583-592Minchinton A.I. Tannock I.F. Drug penetration in solid tumors Nat. Rev. Cancer 2006 6 583 59210.1038/nrc189316862189Search in Google Scholar

[67]Fang J., Nakamura H., Maeda H.: The EPR effect: Unique features of tumour blood vessels for drug delivery, factors involved and limitations and augmentation of the effect. Adv. Drug Deliv. Rev., 2011; 63: 136-151Fang J. Nakamura H. Maeda H. The EPR effect: Unique features of tumour blood vessels for drug delivery, factors involved and limitations and augmentation of the effect Adv. Drug Deliv. Rev 2011 63 136 15110.1016/j.addr.2010.04.00920441782Search in Google Scholar

[68]Maeda H.: Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects. Bioconjug. Chem., 2010; 21: 797-802Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects Bioconjug. Chem 2010 21 797 80210.1021/bc100070g20397686Search in Google Scholar

[69]Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R.: Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol., 2007; 2: 751-760Peer D. Karp J.M. Hong S. Farokhzad O.C. Margalit R. Langer R. Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol 2007 2 751 76010.1201/9780429399039-2Search in Google Scholar

[70]Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.A., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D. i wsp.: Photodynamic therapy of cancer: An update. CA Cancer J. Clin., 2011; 61: 250-281Agostinis P. Berg K. Cengel K.A. Foster T.H. Girotti A.W. Gollnick S.A. Hahn S.M. Hamblin M.R. Juzeniene A. Kessel D. i wsp. Photodynamic therapy of cancer: An update CA Cancer J. Clin 2011 61 250 28110.3322/caac.20114320965921617154Search in Google Scholar

[71]Allison R.R.: Photodynamic therapy: Oncologic horizons. Future Oncol., 2014; 10: 123-124Allison R.R. Photodynamic therapy: Oncologic horizons Future Oncol 2014 10 123 12410.2217/fon.13.17624328413Search in Google Scholar

[72]Kou J., Dou D., Yang L.: Porphyrin photosensitizers in photodynamic therapy and its applications. Oncotarget, 2017; 8: 8159181603Kou J. Dou D. Yang L. Porphyrin photosensitizers in photodynamic therapy and its applications Oncotarget 2017 8 815918160310.18632/oncotarget.20189Search in Google Scholar

[73]Allison R.R., Mota H.C., Sibata C.H.: Clinical PD/PDT in North America: An historical review. Photodiagnosis Photodyn. Ther., 2004; 1: 263-277Allison R.R. Mota H.C. Sibata C.H. Clinical PD/PDT in North America: An historical review Photodiagnosis Photodyn. Ther 2004 1 263 27710.1016/S1572-1000(04)00084-5Search in Google Scholar

[74]Kessel D.: More adventures in photodynamic therapy. Int. J. Mol. Sci., 2015; 16: 15188-15193Kessel D. More adventures in photodynamic therapy Int. J. Mol. Sci 2015 16 15188 1519310.3390/ijms160715188451989426151850Search in Google Scholar

[75]Dolmans D., Fukumura D., Jain R.K.: Photodynamic therapy for cancer. Nat. Rev. Cancer, 2003; 3: 380-387Dolmans D. Fukumura D. Jain R.K. Photodynamic therapy for cancer Nat. Rev. Cancer 2003 3 380 38710.1038/nrc107112724736Search in Google Scholar

[76]Zeitouni N.C., Oseroff A.R., Shieh S.: Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol. Immunol., 2003; 39: 1133-1136Zeitouni N.C. Oseroff A.R. Shieh S. Photodynamic therapy for nonmelanoma skin cancers Current review and update. Mol. Immunol 2003 39 1133 113610.1016/S0161-5890(03)00083-XSearch in Google Scholar

[77]Pariser D.M., Lowe N.J., Stewart D.M., Jarratt M.T., Lucky A.W., Pariser R.J., Yamauchi P.S.: Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial. J. Am. Acad. Dermatol., 2003; 48: 227-232Pariser D.M. Lowe N.J. Stewart D.M. Jarratt M.T. Lucky A.W. Pariser R.J. Yamauchi P.S. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial J. Am. Acad. Dermatol 2003 48 227 23210.1067/mjd.2003.4912582393Search in Google Scholar

[78]Szeimies R.M., Karrer S., Radakovic-Fijan S., Tanew A., Calzavara-Pinton P.G., Zane C., Sidoroff A., Hempel M., Urlich J., Proebstle T. i wsp.: Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J. Am. Acad. Dermatol., 2002; 47: 258-262Szeimies R.M. Karrer S. Radakovic-Fijan S. Tanew A. Calzavara-Pinton P.G. Zane C. Sidoroff A. Hempel M. Urlich J. Proebstle T. i wsp. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study J. Am. Acad. Dermatol 2002 47 258 26210.1067/mjd.2002.119649Search in Google Scholar

[79]Kang H.K., Yun J.H., Son Y.M., Roh J.Y., Lee J.R.: Photodynamic therapy for Bowen’s disease of the vulva area. Ann. Dermatol., 2014; 26: 241-245Kang H.K. Yun J.H. Son Y.M. Roh J.Y. Lee J.R. Photodynamic therapy for Bowen’s disease of the vulva area Ann. Dermatol 2014 26 241 24510.5021/ad.2014.26.2.241403767924882981Search in Google Scholar

[80]Fiechter S., Skaria A., Nievergelt H., Anex R., Borradori L., Parmentier L.: Facial basal cell carcinomas recurring after photodynamic therapy: A retrospective analysis of histological subtypes. Dermatology., 2012; 224: 346-351Fiechter S. Skaria A. Nievergelt H. Anex R. Borradori L. Parmentier L. Facial basal cell carcinomas recurring after photodynamic therapy: A retrospective analysis of histological subtypes Dermatology 2012 224 346 35110.1159/00033933522759732Search in Google Scholar

[81]Griffin L., Lear J.T.: Photodynamic therapy and non-melanoma skin cancer. Cancers, 2016; 8: 98Griffin L. Lear J.T. Photodynamic therapy and non-melanoma skin cancer Cancers 2016 8 9810.3390/cancers8100098508238827782094Search in Google Scholar

[82]Zane C., Capezzera R., Sala R., Venturini M., Calzavara-Pinton P.: Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin. Lasers Surg. Med., 2007; 39: 203-209Zane C. Capezzera R. Sala R. Venturini M. Calzavara-Pinton P. Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin Lasers Surg. Med 2007 39 203 20910.1002/lsm.2047017311325Search in Google Scholar

[83]Hayami J., Okamoto H., Sugihara A., Horio T.: Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J. Dermatol., 2007; 34: 320-327Hayami J. Okamoto H. Sugihara A. Horio T. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid J. Dermatol 2007 34 320 32710.1111/j.1346-8138.2007.00280.xSearch in Google Scholar

[84]Boen M., Brownell J., Patel P., Tsoukas M.M.: The role of photodynamic therapy in acne: An evidence-based review. Am. J. Clin. Dermatol., 2017; 18: 311-321Boen M. Brownell J. Patel P. Tsoukas M.M. The role of photodynamic therapy in acne: An evidence-based review Am. J. Clin. Dermatol 2017 18 311 32110.1007/s40257-017-0255-3Search in Google Scholar

[85]Jugeau S., Tenaud I., Knol A.C., Jarrousse V., Quereux G., Khammari A., Dreno B.: Induction of toll-like receptors by Propionibacterium acnes. Br. J. Dermatol., 2005; 153: 1105-1113Jugeau S. Tenaud I. Knol A.C. Jarrousse V. Quereux G. Khammari A. Dreno B. Induction of toll-like receptors by Propionibacterium acnes Br. J. Dermatol 2005 153 1105 111310.1111/j.1365-2133.2005.06933.xSearch in Google Scholar

[86]Steinbauer J.M., Schreml S., Kohl E.A., Karrer S., Landthaler M., Szeimies R.M.: Photodynamic therapy in dermatology. J. Dtsch. Dermatol. Ges., 2010; 8: 454-464Steinbauer J.M. Schreml S. Kohl E.A. Karrer S. Landthaler M. Szeimies R.M. Photodynamic therapy in dermatology J. Dtsch. Dermatol. Ges 2010 8 454 46410.1111/j.1610-0387.2010.07343.xSearch in Google Scholar

[87]Klein A., Balibas P., Karrer S., Landthaler M., Szeimies R.M.: Photodynamic therapy in dermatology – an update. J. Dtsch. Dermatol. Ges., 2008; 6: 839-845Klein A. Balibas P. Karrer S. Landthaler M. Szeimies R.M. Photodynamic therapy in dermatology – an update J. Dtsch. Dermatol. Ges 2008 6 839 845Search in Google Scholar

[88]Gold M.H., Bradshaw V.L., Boring M.M., Bridges T.M., Biron J.A.: Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol. Surg., 2006; 32: 795-801Gold M.H. Bradshaw V.L. Boring M.M. Bridges T.M. Biron J.A. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage Dermatol. Surg 2006 32 795 80110.1097/00042728-200606000-00006Search in Google Scholar

[89]Zane C., Venturini M., Sala R., Calzavara-Pinton P.: Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol. Photoimmunol. Photomed., 2006; 22: 254-258Zane C. Venturini M. Sala R. Calzavara-Pinton P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma Photodermatol. Photoimmunol. Photomed 2006 22 254 25810.1111/j.1600-0781.2006.00246.xSearch in Google Scholar

[90]Carrascosa J.M.: Fototerapia y fotoquimioterapia. Actas Dermosifiliogr., 2004; 95: 259-284Carrascosa J.M. Fototerapia y fotoquimioterapia Actas Dermosifiliogr 2004 95 259 28410.1016/S0001-7310(04)76817-9Search in Google Scholar